Biocon and Siro Clinpharm in talks

By Gareth Macdonald

- Last updated on GMT

Related tags Clinical trial Contract research organization

Biotechnology firm Biocon is in talks with CRO Siro Clinpharm about a potential partnership, according to reports in the Indian media.

The, as yet unconfirmed, speculation is that Biocon is seeking to make an investment in privately-owned Siro in a bid to expand its Clingene contract research services business.

Siro spokesman Aniruddh Patwardhan confirmed that talks are ongoing, but declined to provide any additional information when contacted by Outsourcing-pharma.

Speaking to the Economic Times, Biocon chairman Kiran Mazumdar-Shaw said: “We are looking at an alliance with Siro Clinpharm that could entail bundling of complementary services​.”

She added however that: “These are ongoing discussions [and] no alliance has fructified yet​.”

Fructified or otherwise, an alliance would certainly provide a boost for Clinigene, given both Siro’s expertise and experience in conducting late phase clinical trials and considerable global reach.

Earlier this month​ the Indian contract research organisation (CRO) rebranded and relaunched trials units in Germany, Greece, Romania, Estonia and Israel that it gained in 2008 with the acquisition of German counterpart Omega Mediation​ .

Siro also has partnerships with UK regulatory affairs specialist CambReg​ and French early-stage contract drug development group Mediscis Medical Science Services.

For Bangalore-based Biocon, access to such a European network would provide an attractive way of expanding its CRO business, particularly at a time when demand for clinical trials in central and Eastern Europe is strong.

Outside Europe, Siro has a relationship with US group Advanced Clinical Trial Solutions​ (ACT) focused on the provision of trial services for the development of anti-cancer drugs.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us